Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
vonoprazan + amoxicillin + doxycycline + bismuth
- Development stage
- Unknown
- Lead developer
- Phathom Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
A quadruple therapy regimen used for Helicobacter pylori (H. pylori) eradication. It combines vonoprazan (a potassium-competitive acid blocker that decreases stomach acid production), amoxicillin (an antibiotic that kills bacteria or prevents their growth), doxycycline (a tetracycline antibiotic with lower toxicity than other tetracyclines), and bismuth (usually in the form of colloidal bismuth tartrate or bismuth subsalicylate). This combination represents an evolution in H. pylori treatment approaches, particularly for patients who may have renal insufficiency or cannot tolerate standard tetracycline.
02
Targets
PBP (Penicillin-binding protein family)ATP4A (Potassium–transporting ATPase alpha chain 1)Bacterial Ribosome
Beyond the preview
Go deeper on vonoprazan + amoxicillin + doxycycline + bismuth.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on vonoprazan + amoxicillin + doxycycline + bismuth.